Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Altoderm in children with atopic dermatitis
ISRCTN02084571Phase 3Completed
- Sponsor
- Thornton & Ross
- Start
- Apr 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of alclometasone in atopic dermatitis (AD) (2 arms), sponsored by Thornton & Ross. Primary endpoints: Change from baseline in SCORAD score at end of trial and Change from baseline in skin itch element of SCORAD at end of trial. Started Apr 2009; status: completed.
02
Drugs
alclometasone
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on ISRCTN02084571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN02084571.